Northern Trust’s Ventyx Biosciences VTYX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | – | Sell |
-135,422
| Closed | -$1.22M | – | 4541 |
|
|
2025
Q4 | $1.22M | Buy |
135,422
+4,950
| +4% | +$37K | ﹤0.01% | 3267 |
|
|
2025
Q3 | $406K | Hold |
130,472
| – | – | ﹤0.01% | 3726 |
|
|
2025
Q2 | $279K | Sell |
130,472
-349,859
| -73% | -$565K | ﹤0.01% | 3825 |
|
|
2025
Q1 | $552K | Sell |
480,331
-5,333
| -1% | -$9.16K | ﹤0.01% | 3538 |
|
|
2024
Q4 | $1.06M | Buy |
485,664
+19,982
| +4% | +$45.3K | ﹤0.01% | 3361 |
|
|
2024
Q3 | $1.02M | Buy |
465,682
+71,622
| +18% | +$165K | ﹤0.01% | 3351 |
|
|
2024
Q2 | $910K | Sell |
394,060
-3,017
| -0.8% | -$12.5K | ﹤0.01% | 3290 |
|
|
2024
Q1 | $2.18M | Sell |
397,077
-56,638
| -12% | -$259K | ﹤0.01% | 2915 |
|
|
2023
Q4 | $1.12M | Buy |
453,715
+34,777
| +8% | +$330K | ﹤0.01% | 3277 |
|
|
2023
Q3 | $14.5M | Buy |
418,938
+35,581
| +9% | +$1.23M | ﹤0.01% | 1755 |
|
|
2023
Q2 | $12.6M | Buy |
383,357
+161,613
| +73% | +$5.57M | ﹤0.01% | 1891 |
|
|
2023
Q1 | $7.43M | Buy |
221,744
+5,678
| +3% | +$221K | ﹤0.01% | 2218 |
|
|
2022
Q4 | $7.08M | Buy |
216,066
+32,130
| +17% | +$952K | ﹤0.01% | 2240 |
|
|
2022
Q3 | $6.42M | Buy |
183,936
+17,293
| +10% | +$383K | ﹤0.01% | 2304 |
|
|
2022
Q2 | $2.04M | Buy |
166,643
+80,391
| +93% | +$1.2M | ﹤0.01% | 3054 |
|
|
2022
Q1 | $1.17M | Sell |
86,252
-7,113
| -8% | -$95K | ﹤0.01% | 3352 |
|
|
2021
Q4 | $1.85M | Buy |
+93,365
| New | +$1.77M | ﹤0.01% | 3247 |
|
Other funds holding VTYX
Northern Trust's VTYX Position: Q1 2026 in Review
Northern Trust sold out of Ventyx Biosciences (VTYX) in Q1 2026, closing a stake of 135,422 shares — an estimated $1.22M sold.
Northern Trust first reported a position in VTYX in Q4 2021 and held it in 17 quarters. The position peaked at $14.5M in Q3 2023. 1 fund tracked by Wall St. Rank holds VTYX as of Q1 2026.
- Northern Trust reported no remaining Ventyx Biosciences position as of Q1 2026 after selling out during the quarter.
- Northern Trust sold 135,422 Ventyx Biosciences shares in Q1 2026, an estimated $1.22M.
- Northern Trust first reported a position in Ventyx Biosciences in Q4 2021 and held it in 17 quarters.
- Northern Trust's Ventyx Biosciences position peaked at $14.5M in Q3 2023.
- 1 fund tracked by Wall St. Rank held Ventyx Biosciences as of Q1 2026.
Based on Northern Trust's 13F filing for Q1 2026, filed 14 May 2026.